2010
DOI: 10.1016/j.jchromb.2010.08.045
|View full text |Cite
|
Sign up to set email alerts
|

Quantification of the 15 major human bile acids and their precursor 7α-hydroxy-4-cholesten-3-one in serum by liquid chromatography–tandem mass spectrometry

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
62
2

Year Published

2012
2012
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 76 publications
(66 citation statements)
references
References 26 publications
1
62
2
Order By: Relevance
“…The use of MS operating in the MRM mode enabled the accomplishment of high sensitivity, reliable quantifi cation, and a wide dynamic range. The proposed instrumental confi guration offers a key advantage over other MS methods ( 13,21,35 ), allowing the profi ling of a larger number of BAs. Moreover, the high sensitivity attained, if compared with other previously reported methods ( 20-24, 28, 30, 36 ), considerably reduces sample requirements because now 25 l of serum and 5 mg of liver tissue suffi ce to perform proper BA profi ling.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…The use of MS operating in the MRM mode enabled the accomplishment of high sensitivity, reliable quantifi cation, and a wide dynamic range. The proposed instrumental confi guration offers a key advantage over other MS methods ( 13,21,35 ), allowing the profi ling of a larger number of BAs. Moreover, the high sensitivity attained, if compared with other previously reported methods ( 20-24, 28, 30, 36 ), considerably reduces sample requirements because now 25 l of serum and 5 mg of liver tissue suffi ce to perform proper BA profi ling.…”
Section: Discussionmentioning
confidence: 99%
“…Changes in BA profi les can be used as biomarkers of disease ( 10,17,18 ), and, therefore, accurate and sensitive techniques are required for the comprehensive profi ling BAs, including those found at relatively low concentrations in physiological conditions. A number of LC/MS methods have been developed for this purpose, but their extensive sample processing and their limited capacity to detect minor BAs ( 11,(19)(20)(21)(22)(23)(24)(25) have restrained their use. In fact, detection of low-concentrated or unusual BAs in human samples, is an important target of BA profi ling given their important role in some pathological situations ( 10,13,26 ).…”
Section: Uplc-ms Analysismentioning
confidence: 99%
See 1 more Smart Citation
“…Individual bile acid concentrations in plasma (day 14), bile, and frozen liver samples (day 14) were quantifi ed by capillary gas chromatography and further characterized by LC-MS/MS as described previously (16)(17)(18). Plasma 7 ␣ -hydroxy-4-cholesten-3-one (C4) concentrations were determined as described previously ( 19 ). Plasma bile acid pool was calculated as the product of plasma total bile acid concentration ( M) and blood volume assuming 80 ml/kg body weight.…”
Section: Immunoblot Analysismentioning
confidence: 99%
“…Surprisingly, T-CDCA, T-DCA, T-LCA, T-b-MCA and T-UDCA reached LLOQs at the pM range and are remarkably lower than those of previous studies (Table 3). 18,23 This can be explained by employing MRM and using specic fragments for quantication of BAs, thereby reducing the SNR in the second mass lter and improving sensitivity. Recently, García-Cañaveras et al reported comparable LLOQs for a number of unconjugated BAs in 25 mL of sample volume using SIM operated in negative ion mode, differences that are likely to be caused by different sensitivities of the instruments used.…”
Section: -23mentioning
confidence: 99%